ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for alerts 登録してリアルタイムのアラート、カスタムポートフォリオ、市場の動きを入手してください。
Caesarstone Ltd

Caesarstone Ltd (CSTE)

4.68
-0.18
( -3.70% )
更新日時: 00:01:24

リアルタイムのディスカッションと取引のアイデア: 当社の強力なプラットフォームで自信を持って取引できます。

主要統計と詳細

通貨
4.68
買値
4.62
売値
4.69
出来高
67,181
4.3595 日の範囲 4.77
3.5002 52 週間の範囲 6.81
時価総額
前日終値
4.86
始値
4.71
時刻
6
@
4.65
最終取引時間
00:04:44
財務取引量
US$ 309,374
VWAP
4.6051
平均取引量 (3 か月)
137,562
発行済株式数
34,532,452
配当利回り
-
PER
-1.47
1 株当たり利益 (EPS)
-3.12
歳入
570M
純利益
-107.66M

Caesarstone Ltd について

Caesarstone Ltd manufactures engineered quartz surfaces. Its products primarily include engineered quartz and porcelain slabs, which are used as kitchen countertops in renovation and remodeling, and residential construction. It also has other applications, including vanity tops, wall panels, backspl... Caesarstone Ltd manufactures engineered quartz surfaces. Its products primarily include engineered quartz and porcelain slabs, which are used as kitchen countertops in renovation and remodeling, and residential construction. It also has other applications, including vanity tops, wall panels, backsplashes, floor tiles, stairs, and other interior surfaces that are used in various residential and non-residential applications. The company sells its products under the Caesarstone brand. Caesarstone's geographical segments are the United States, Canada, Latin America, Australia, Asia, Israel, and EMEA(Europe, Middle East, Africa). 詳細を表示

セクター
Cut Stone And Stone Products
業界
Cut Stone And Stone Products
ウェブサイト
本社
Hadera, North, Isr
設立
1970
Caesarstone Ltd is listed in the Cut Stone And Stone Products sector of the ナスダック市場 with ticker CSTE. The last closing price for Caesarstone was US$4.86. Over the last year, Caesarstone shares have traded in a share price range of US$ 3.5002 to US$ 6.81.

Caesarstone currently has 34,532,452 shares in issue. The market capitalisation of Caesarstone is US$167.83 million. Caesarstone has a price to earnings ratio (PE ratio) of -1.47.

CSTE 最新ニュース

PAOG BREAKOUT ALERT - Breaking 50 Day MA on MACD Cross

Aprill 12, 2021 -- InvestorsHub NewsWire -- via Stockcharts.com/PAOG PAOG News Out On CBD RX Update   PAOG Advances CBD Pharmaceutical Developments Backed By US...

MultiCell Immunotherapeutics And Oxis Biotech Sign Antibody-Drug Conjugate R&D, Product License And Commercialization Agreeme...

MultiCell Immunotherapeutics And Oxis Biotech Sign Antibody-Drug Conjugate R&D, Product License And Commercialization Agreement PR Newswire WOONSOCKET, R.I., March 12, 2015 WOONSOCKET, R.I...

MultiCell Technologies Files Novel Antibody-Drug Conjugate Patent Application

MultiCell Technologies Files Novel Antibody-Drug Conjugate Patent Application PR Newswire WOONSOCKET, R.I., Dec. 10, 2014 WOONSOCKET, R.I., Dec. 10, 2014 /PRNewswire/ -- MultiCell Technologies...

MultiCell Technologies Granted U.S. Patent Covering Therapeutics Which Fight Virus Infection And Cancer

MultiCell Technologies Granted U.S. Patent Covering Therapeutics Which Fight Virus Infection And Cancer PR Newswire WOONSOCKET, R.I., Aug. 25, 2014 WOONSOCKET, R.I., Aug. 25, 2014 /PRNewswire/...

MultiCell Technologies Files U.S. and International Patent Applications for the Treatment of Liver Cancer

MultiCell Technologies Files U.S. and International Patent Applications for the Treatment of Liver Cancer PR Newswire WOONSOCKET, R.I., March 20, 2014 WOONSOCKET, R.I., March 20, 2014...

MultiCell Technologies Files Patent Application Covering New Class of RNA Therapeutics

MultiCell Technologies Files Patent Application Covering New Class of RNA Therapeutics PR Newswire WOONSOCKET, R.I., Jan. 15, 2014 WOONSOCKET, R.I., Jan. 15, 2014 /PRNewswire/ -- MultiCell...

MultiCell Technologies Files U.S. Patent Application for Targeted Delivery of MCT-485, a Noncoding miRNA for Cancer Treatment

MultiCell Technologies Files U.S. Patent Application for Targeted Delivery of MCT-485, a Noncoding miRNA for Cancer Treatment PR Newswire WOONSOCKET, R.I., Nov. 13, 2013 WOONSOCKET, R.I., Nov...

MultiCell Technologies Expands Scope of Research Agreement for the Treatment of Liver Cancer

MultiCell Technologies Expands Scope of Research Agreement for the Treatment of Liver Cancer PR Newswire WOONSOCKET, R.I., Oct. 2, 2013 WOONSOCKET, R.I., Oct. 2, 2013 /PRNewswire/ -- MultiCell...

MultiCell Technologies and Genisphere Evaluate Targeted Delivery of MCT-485, a Noncoding miRNA for the Treatment of Cancer

MultiCell Technologies and Genisphere Evaluate Targeted Delivery of MCT-485, a Noncoding miRNA for the Treatment of Cancer PR Newswire WOONSOCKET, R.I., Aug. 6, 2013 WOONSOCKET, R.I., Aug. 6...

期間 †前日比前日比 %始値高値安値平均出来高VWAP
1-1.71-26.76056338036.396.544.35951010765.48199096CS
4-0.57-10.85714285715.256.544.3595933225.79094663CS
12-1.71-26.76056338036.396.544.35951375625.36203528CS
260.717.58793969853.986.813.761123935.30913135CS
52-0.73-13.49353049915.416.813.5002793614.97553086CS
156-8.99-65.764447695713.6714.433.50021043157.44153649CS
260-11.34-70.786516853916.0219.8033.50021140239.98740182CS

ムーバー

すべて表示
  • 出来高
  • 値上がり率
  • 値下がり率
銘柄コード株価出来高
CDTConduit Pharmaceuticals Inc
US$ 0.3139
(90.24%)
243.49M
TOIIWOncology Institute Inc
US$ 0.0264
(63.98%)
15.8k
HROWHarrow Inc
US$ 32.654
(48.56%)
1.75M
GVPGSE Systems Incorporated
US$ 3.96
(45.05%)
1.44M
XPELXPEL Inc
US$ 45.405
(43.01%)
410.96k
OMOutset Medical Inc
US$ 1.395
(-58.97%)
6.3M
CDLXCardlytics Inc
US$ 3.0001
(-56.52%)
7.65M
ENTOEntero Therapeutics Inc
US$ 0.2799
(-55.07%)
889.89k
FBLGFibroBiologics Inc
US$ 2.11
(-43.43%)
183.08k
EGHT8x8 Inc
US$ 1.625
(-37.02%)
2.19M
CDTConduit Pharmaceuticals Inc
US$ 0.3139
(90.24%)
243.49M
NVDANVIDIA Corporation
US$ 102.4303
(3.56%)
143.4M
XPONExpion360 Inc
US$ 0.094
(12.57%)
110.45M
SQQQProShares UltraPro Short QQQ
US$ 10.06
(-7.11%)
88.11M
WENAANEW MEDICAL INC
US$ 1.2208
(12.00%)
42.66M

CSTE Discussion

投稿を表示

最近閲覧した銘柄

Delayed Upgrade Clock